- Home
- FDMT vs FPH Comparison
FDMT vs FPH Comparison
Compare FDMT & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- FPH
- Stock Information
- Founded
- FDMT 2013
- FPH 2009
- Country
- FDMT United States
- FPH United States
- Employees
- FDMT N/A
- FPH N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- FPH Real Estate
- Sector
- FDMT Health Care
- FPH Finance
- Exchange
- FDMT Nasdaq
- FPH Nasdaq
- Market Cap
- FDMT 268.6M
- FPH 271.3M
- IPO Year
- FDMT 2020
- FPH 2017
- Fundamental
- Price
- FDMT $4.67
- FPH $4.03
- Analyst Decision
- FDMT Buy
- FPH
- Analyst Count
- FDMT 11
- FPH 0
- Target Price
- FDMT $41.70
- FPH N/A
- AVG Volume (30 Days)
- FDMT 1.1M
- FPH 249.8K
- Earning Date
- FDMT 02-27-2025
- FPH 01-23-2025
- Dividend Yield
- FDMT N/A
- FPH N/A
- EPS Growth
- FDMT N/A
- FPH 35.57
- EPS
- FDMT N/A
- FPH 0.70
- Revenue
- FDMT $17,000.00
- FPH $196,899,000.00
- Revenue This Year
- FDMT N/A
- FPH N/A
- Revenue Next Year
- FDMT $159.49
- FPH N/A
- P/E Ratio
- FDMT N/A
- FPH $5.81
- Revenue Growth
- FDMT N/A
- FPH 79.04
- 52 Week Low
- FDMT $4.48
- FPH $2.83
- 52 Week High
- FDMT $36.25
- FPH $4.39
- Technical
- Relative Strength Index (RSI)
- FDMT 32.64
- FPH 63.53
- Support Level
- FDMT $4.68
- FPH $3.60
- Resistance Level
- FDMT $5.15
- FPH $4.15
- Average True Range (ATR)
- FDMT 0.41
- FPH 0.13
- MACD
- FDMT -0.05
- FPH 0.05
- Stochastic Oscillator
- FDMT 8.69
- FPH 80.59
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About FPH Five Point Holdings LLC
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational and recreational elements, as well as civic areas, parks, and open spaces. Its four reportable segments are Valencia, San Francisco, Great Park, and Commercial. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.